Melle

Researchers are evaluating the fluid absorption performance of two commonly used CE-marked superabsorbent dressings, Cutimed Sorbion and Zetuvit plus (RespoSorb), when applied to venous leg ulcers (VLUs) in routine wound care. The study aims to determine differences in how these dressings manage wound exudate and their ability to prevent skin maceration and leakage, which are important factors in promoting wound healing. Participants will receive one of the two superabsorbent dressings applied directly to their venous leg ulcer. The dressings are intended to maintain wound exudate effectively. This is a prospective, multicenter, partially assessor-blinded, randomized, open-label, parallel, comparative clinical trial comparing the exudate management performance of these products. During the study, participants will be monitored for up to 30 days to assess the dressings' ability to manage exudate. Researchers will evaluate the dressings' absorption performance, as well as any effects on skin maceration and leakage. Participants are expected to comply with study visits and standard therapies such as compression treatment while their wounds and overall health are regularly assessed throughout the study period.